- Previous Close
0.445 - Open
0.365 - Bid 0.305 x --
- Ask 0.500 x --
- Day's Range
0.365 - 0.430 - 52 Week Range
0.365 - 0.900 - Volume
70,000 - Avg. Volume
347 - Market Cap (intraday)
177.546M - Beta (5Y Monthly) 0.40
- PE Ratio (TTM)
-- - EPS (TTM)
-0.040 - Earnings Date Mar 28, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Apr 14, 2008
- 1y Target Est
--
China Tian Yuan Healthcare Group Limited, an investment holding company, provides healthcare related services in Hong Kong, Korea, the People's Republic of China, and Korea. It operates through Investment Holding, Healthcare, Money Lending and Related Business, and Hospitality segments. The company offers procurement, marketing, and management services to the medical industry; and plastic surgery and medical beauty services, as well as licenses trademarks. It also invests in equity investments; offers loans and related services; refers and introduces lenders and borrowers; and provides procurement services to the hospitality industry. The company was formerly known as City e-Solutions Limited and changed its name to China Tian Yuan Healthcare Group Limited in November 2017. The company was incorporated in 1990 and is based in Wan Chai, Hong Kong. China Tian Yuan Healthcare Group Limited is a subsidiary of Tian Yuan Manganese Limited.
www.tianyuanhealthcare.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 0557.HK
View MorePerformance Overview: 0557.HK
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0557.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0557.HK
View MoreValuation Measures
Market Cap
177.55M
Enterprise Value
194.61M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.89
Price/Book (mrq)
0.79
Enterprise Value/Revenue
5.36
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-127.54%
Return on Assets (ttm)
-1.63%
Return on Equity (ttm)
-19.74%
Revenue (ttm)
26.84M
Net Income Avi to Common (ttm)
-34.24M
Diluted EPS (ttm)
-0.040
Balance Sheet and Cash Flow
Total Cash (mrq)
27.05M
Total Debt/Equity (mrq)
23.26%
Levered Free Cash Flow (ttm)
--